Goh, Yonggeng http://orcid.org/0000-0003-3149-0295
Chou, Chen-Pin
Chan, Ching Wan
Buhari, Shaik Ahmad
Hartman, Mikael
Tang, Siau Wei
Ng, Celene Wei Qi
Pillay, Premilla
Chua, Wynne
Jagmohan, Pooja
Sterling, Eide
Wong, Ying Mei
Tan, Loon Ying
Ong, Han Yang
Pan, Huay-Ben
Lee, Herng-Sheng
Hung, Bao-Hui
Quek, Swee Tian
Funding for this research was provided by:
NUHS Seed Fund
Article History
Received: 14 April 2022
Revised: 14 May 2022
Accepted: 20 May 2022
First Online: 5 July 2022
Declarations
:
: The scientific guarantor of this publication is Dr. Goh Yonggeng.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Ms. Yap Qai Wen from the National University of Singapore (NUS) Medicine Biostatistics Unit for assistance in biostatistics kindly provided statistical advice for this manuscript.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: There are subject/cohort overlap for the patients enrolled in this current study with a previous study that compared CEM and breast MRI (Eur J Radiol. 2015 Dec;84(12):2501-8).Of the 200 women who participated in our current study, 69 individuals had previously participated in a study that compared the diagnostic value of CEM and breast MRI for suspicious breast lesions before biopsies. There was no discussion of surgical management with CEM in the previous study. Our current study has a larger cohort for CEM of breast malignancies, and there is no substantial data redundancy between the two studies.The IRB full names and approval numbers are as follows:This study at KSVGH: KAOHSIUNG V.G.H. Institutional Review Board. IRB No: KSVGH22-CT2-18.Early study at KSVGH in 2012: KAOHSIUNG V.G.H. Institutional Review Board. IRB No: VGHKS11-CT4-16.NUH: “National Healthcare Group Domain Specific Review Board” (NHG DSRB).Approval number: 2016/00508.
: • retrospective• cross-sectional study• multicenter study